INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2010

Milled flaxseed and flaxseed oil increased plasma phospholipid n-3 fatty acids without altering glycemic control in adults with type 2 diabetes.

Thirty-four adults with type 2 diabetes were randomized to consume bakery products daily for 12 weeks containing no flax (control, n=9), milled flaxseed (32 g/d, n=13), or flaxseed oil (13 g/d, n=12; both flax groups provided 7.4 g/d alpha-linolenic acid). Both flax groups had increases in plasma phospholipid n-3 fatty acids (ALA, EPA, or DPA, but not DHA), and the flaxseed oil group had more EPA and DPA compared to the milled flaxseed group. The control group experienced a 4% weight gain compared to baseline (p < 0.05), while weight remained constant in both flax groups. All other parameters, including glycemic control, were unchanged by dietary treatment.

Study type
Parallel randomized controlled trial
Who was studied
34 adults with type 2 diabetes (17 men, 17 women; age 52.4 +/- 1.5 years, BMI 32.4 +/- 1.0 kg/m2)
What was measured
Fasting HbA1c, glucose, insulin, phospholipid fatty acids, leptin, adiponectin, body weight, BMI, and waist circumference

THE PAPER

Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes.

Taylor CG, Noto AD, Stringer DM, Froese S, Malcolmson L. J Am Coll Nutr, 2010.

PubMed 20595648 ↗DOI 10.1080/07315724.2010.10719819 ↗

Diabetes & blood sugarNutrients & adequacyWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.